Advertisement
MTD vs RVTY
Which Stock Would AI Choose? Mettler-Toledo International Inc. (MTD) vs. Revvity, Inc. (RVTY) Stock Comparison
Key Takeaways
- Mettler-Toledo International Inc. (MTD) holds a larger market capitalization of approximately $25B, dwarfing Revvity, Inc. (RVTY)'s $9.7B, reflecting greater scale in precision instruments.
- Year-to-date performance shows RVTY slightly ahead at 10.2% gains compared to MTD's 9.77%, amid broader market recovery.
- Both stocks face upcoming Q1 2026 earnings reports, with analysts projecting EPS growth for MTD and mixed outlooks for RVTY.
- Analyst price targets imply ~16% upside for MTD to $1,488 and higher ~31% potential for RVTY to $114, signaling value opportunities.
- Recent market activity highlights stability in MTD with price recovery, while RVTY shows innovation catalysts in cancer research tools.
Introduction
This stock comparison pits Mettler-Toledo International Inc. (MTD) against Revvity, Inc. (RVTY), two leaders in the life sciences and precision instruments sector. Both companies supply essential tools to pharmaceutical, biotech, and research markets, benefiting from steady demand in laboratory and diagnostics applications. Traders seeking exposure to healthcare innovation and industrial precision may find this analysis valuable, especially amid recent market volatility and upcoming earnings seasons. Investors focused on relative performance and sector positioning can gauge trade-offs in growth, valuation, and momentum between these peers.
MTD Overview and Recent Performance
Mettler-Toledo International Inc. (MTD) is a global supplier of precision instruments and services, including laboratory balances, pipetting solutions, thermal analysis systems, and industrial weighing equipment. Serving pharma, biotech, food, and chemical industries, it operates across Americas, Europe, and Asia. In recent market activity, MTD shares have exhibited resilience, trading around $1,258 with a 52-week range of $1,052-$1,525. Year-to-date gains stand at 9.77%, supported by a Q4 2025 earnings beat where sales rose 8% and adjusted EPS increased. Sentiment reflects mixed analyst views ahead of Q1 2026 results, influenced by stagnant revenue concerns offset by strong capital returns and conference presentations. Price recovery in recent weeks underscores investor confidence in its diversified operations.
RVTY Overview and Recent Performance
Revvity, Inc. (RVTY), formerly PerkinElmer, delivers health sciences solutions like reagents, instruments, and software for diagnostics and genomic workflows. It targets early disease detection, oncology, and drug discovery, serving labs, pharma, and public health entities worldwide. Shares recently hovered near $87, within a 52-week span of $81-$118, with YTD returns of 10.2%. Recent developments include quarterly dividend declarations, board re-elections, and showcases of cancer research platforms at AACR 2026. Performance has been tempered by revenue growth challenges and margin pressures, fostering mixed sentiment as Q1 2026 earnings approach. Innovations in molecular cloning and data tools bolster long-term positioning despite near-term volatility.
Trending AI Robots
Tickeron’s Trending AI Robots page spotlights the platform's elite performers from over 351 AI Trading Bots that scan and trade thousands of tickers across stocks, ETFs, and crypto. This curated section features just 25 top bots, handpicked for their suitability in prevailing market conditions, boasting impressive stats like annualized returns from 40% to 162%, win rates spanning 50% to 88%, and profit-to-drawdown ratios up to 17. Strategies vary widely—short-term 5-minute scalps to multi-day holds—targeting sectors such as semiconductors, industrials, data centers, and small caps with multiple tickers per bot. These virtual agents deliver real-time signals with built-in risk management, appealing to traders seeking data-driven edges. Explore the Trending AI Robots for potential strategies aligned with current trends.
Head-to-Head Comparison
MTD and RVTY share sector exposure in life sciences tools but diverge in business models: MTD emphasizes broad precision hardware for labs and industry, while RVTY leans into reagents, diagnostics, and software for targeted health applications. Growth drivers include pharma R&D demand for both, though RVTY highlights genomics and oncology catalysts versus MTD's industrial diversification. Recent momentum favors MTD's stability post-earnings beats, contrasting RVTY's innovation-driven but margin-challenged trajectory. Risk factors encompass earnings volatility and sector slowdowns, with MTD facing higher valuations (P/E implied higher) and RVTY grappling revenue softness. Market sentiment remains balanced, with analysts noting trade-offs in scale versus undervaluation.
Tickeron AI Verdict
Tickeron’s AI currently favors MTD for its trend consistency, larger scale providing stability, and positive earnings momentum in recent quarters. While RVTY offers compelling upside potential through diagnostics growth, MTD's diversified revenue and relative positioning in precision tools align better with observable market catalysts and lower short-term risks.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTD is a Buy and RVTY is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MTD’s FA Score shows that 1 FA rating(s) are green whileRVTY’s FA Score has 3 green FA rating(s).
- MTD’s FA Score: 1 green, 4 red.
- RVTY’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MTD’s TA Score shows that 5 TA indicator(s) are bullish while RVTY’s TA Score has 5 bullish TA indicator(s).
- MTD’s TA Score: 5 bullish, 4 bearish.
- RVTY’s TA Score: 5 bullish, 4 bearish.
Price Growth
MTD (@Medical Specialties) experienced а +10.39% price change this week, while RVTY (@Medical Specialties) price change was +13.02% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +8.88%. For the same industry, the average monthly price growth was +11.83%, and the average quarterly price growth was +6.31%.
Reported Earning Dates
MTD is expected to report earnings on Jul 23, 2026.
RVTY is expected to report earnings on Aug 03, 2026.
Industries' Descriptions
@Medical Specialties (+8.88% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| MTD | RVTY | MTD / RVTY | |
| Capitalization | 25.5B | 12.6B | 202% |
| EBITDA | 1.25B | 773M | 162% |
| Gain YTD | -9.356 | 16.979 | -55% |
| P/E Ratio | 27.34 | 47.62 | 57% |
| Revenue | 4.09B | 2.9B | 141% |
| Total Cash | 60.6M | 860M | 7% |
| Total Debt | 2.23B | 3.35B | 67% |
MTD | RVTY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 27 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 15 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 2 | 89 | |
PRICE GROWTH RATING 1..100 | 50 | 13 | |
P/E GROWTH RATING 1..100 | 58 | 33 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RVTY's Valuation (15) in the Medical Specialties industry is significantly better than the same rating for MTD (99). This means that RVTY’s stock grew significantly faster than MTD’s over the last 12 months.
RVTY's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MTD (100). This means that RVTY’s stock grew similarly to MTD’s over the last 12 months.
MTD's SMR Rating (2) in the Medical Specialties industry is significantly better than the same rating for RVTY (89). This means that MTD’s stock grew significantly faster than RVTY’s over the last 12 months.
RVTY's Price Growth Rating (13) in the Medical Specialties industry is somewhat better than the same rating for MTD (50). This means that RVTY’s stock grew somewhat faster than MTD’s over the last 12 months.
RVTY's P/E Growth Rating (33) in the Medical Specialties industry is in the same range as MTD (58). This means that RVTY’s stock grew similarly to MTD’s over the last 12 months.
| MTD | RVTY | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 78% | 2 days ago 89% |
| Stochastic ODDS (%) | 2 days ago 72% | 2 days ago 76% |
| Momentum ODDS (%) | 2 days ago 68% | 2 days ago 71% |
| MACD ODDS (%) | 2 days ago 67% | 2 days ago 72% |
| TrendWeek ODDS (%) | 2 days ago 61% | 2 days ago 65% |
| TrendMonth ODDS (%) | 2 days ago 59% | 2 days ago 60% |
| Advances ODDS (%) | 2 days ago 61% | 3 days ago 65% |
| Declines ODDS (%) | 11 days ago 65% | 26 days ago 67% |
| BollingerBands ODDS (%) | 2 days ago 77% | 2 days ago 76% |
| Aroon ODDS (%) | 2 days ago 55% | 2 days ago 49% |
Advertisement
MTD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.
| Ticker / NAME | Correlation To MTD | 1D Price Change % | ||
|---|---|---|---|---|
| MTD | 100% | +1.64% | ||
| A - MTD | 71% Closely correlated | +0.37% | ||
| TMO - MTD | 68% Closely correlated | +1.44% | ||
| BRKR - MTD | 67% Closely correlated | +0.03% | ||
| DHR - MTD | 64% Loosely correlated | +1.75% | ||
| AZTA - MTD | 61% Loosely correlated | +3.53% | ||
More | ||||
RVTY and
Correlation & Price change
A.I.dvisor indicates that over the last year, RVTY has been closely correlated with TMO. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVTY jumps, then TMO could also see price increases.
| Ticker / NAME | Correlation To RVTY | 1D Price Change % | ||
|---|---|---|---|---|
| RVTY | 100% | -0.45% | ||
| TMO - RVTY | 70% Closely correlated | +1.44% | ||
| IQV - RVTY | 66% Loosely correlated | +2.53% | ||
| A - RVTY | 65% Loosely correlated | +0.37% | ||
| DHR - RVTY | 65% Loosely correlated | +1.75% | ||
| CRL - RVTY | 65% Loosely correlated | +1.43% | ||
More | ||||